East Money App Hong Kong Stock Hot List Clarification: Distinction Between Stock Codes 02367.HK and 9966.HK (Alphamab Oncology)
Unlock More Features
Login to access AI-powered analysis, deep research reports and more advanced features
About us: Ginlix AI is the AI Investment Copilot powered by real data, bridging advanced AI with professional financial databases to provide verifiable, truth-based answers. Please use the chat box below to ask any financial question.
Related Stocks
02367.HK appeared as a popular stock on the East Money App Hong Kong Market Popularity List (Tushare dc_hot) [0].
Analysis indicates that 02367.HK is unrelated to Alphamab Oncology, whose correct stock code is 9966.HK [0].
- Share Price Trend: In 2025, the share price peaked at HK$11.52, with a maximum single-day increase of 5.88%, showing characteristics of volatility and significantly amplified trading volume [1].
- Product Progress: Clinical trial status updates for core products KN035 (PD-L1 inhibitor) and KN026 (HER2 bispecific antibody) [2].
- Industry Recognition: Selected into China’s Top 100 Pharmaceutical Innovation Enterprises in 2025 [3].
Alphamab Oncology is ranked alongside peer companies such as Junshi Biosciences and CStone Pharmaceuticals in the Hong Kong stock biotech sector [0].
Insights are generated using AI models and historical data for informational purposes only. They do not constitute investment advice or recommendations. Past performance is not indicative of future results.
About us: Ginlix AI is the AI Investment Copilot powered by real data, bridging advanced AI with professional financial databases to provide verifiable, truth-based answers. Please use the chat box below to ask any financial question.